Genmab — August 2018
-
-
Det er en dejlig historie med datteren som blev helbredt.
-
-
YMAB - "Dansk biotekselskab med Joe & The Juice-stifter i ejerkredsen henter FDA-særstatus" https://medwatch.dk/secure/Medicinal___Biotek/article10822428.ece
-
Tak Doc.
-
Vi har måske her et emne for en supplerende chat og fire årlige Q&A.
-
MD Anderson still writing about the Limo Chen research - https://www.mdanderson.org/publications/cancer-frontline/2018/august-2018/immunotherapy-fires-up-protein-on-tumors-that-supresses-immune-a.html and the big pdf from AACR http://cancerdiscovery.aacrjournals.org/content/candisc/early/2018/07/14/2159-8290.CD-17-1033.full.pdf
-
@Pensionisten. Tvivler paa shorterne har tid til at omprogramere deres robot dagligt. AQR har over 10.000 positioner og jeg formoder det er noget der tager lidt tid at programere deres HFT robot og hvis de skal igennem alle 10.000 positioner hver dag vil da kraeve en del folk paa kontoret. Kender dog ikke til programeringen saa skal ikke kunne sige om det er noget der orned paa faa min eller det tager timer.
-
Tx E L. Well, the fact that they continue research and conclude the same, I suppose it means that there is still hope for dara and PD(L)1-blockers in lung cancer. It shall be interesting to see what the CheckMate studies come up with in terms of pd-1 (nivolumab) and other solid cancers.
-
-
Janssen har dette i NSCLC med atezo og dara. https://clinicaltrials.gov/ct2/show/NCT03023423?term=daratumumab&cond=Lung+Cancer&rank=1
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind